Feedback

Prof. Gaikwad Anil Bhanudas

Professor, Department of Pharmacy,
BITS Pilani, Pilani Campus

Pharmacology
Department of Pharmacy, Birla Institute of Technology & Science, Pilani- 333031, Rajasthan. India.

Sponsored Projects

 

Projects Ongoing

S.No Title of the Project Funding Agency Principal Investigator /Co-investigator Type of project
Amount (Lakhs)

Identification and characterization of novel long non-coding RNAs in AKI-CKD transition using CRISPR/Cas9-based epigenome editing: revealing the potential of long non-coding RNAs as a biomarker and therapeutic strategy   ICMR  Principal Investigator  EMR 41.85
2 Interdisciplinary life science programme for advanced research and education in epigenetics and genome editing DBT Co-Principal Investigator BUILDER 975
3 Novel pharmacological interventions against chronic kidney disease using clinically approved Inodilators, ET-1A antagonists, and Bisphosphonates: drug repurposing approach SERB Principal Investigator EMEQ 36.12
4

Pharmacological intervention using α-Klotho with AT1 receptor blocker and sodium-glucose co-transporter 2 (SGLT-2) inhibitor against diabetic kidney disease

SERB Principal Investigator CRG 38.62

 

Projects Completed

S.No    Title of the Project Funding Agency Principal Investigator /Co-investigator Type of project Amount (Lakhs)
 1 Klotho regulation as a novel therapeutic strategy against acute kidney injury-diabetes comorbidity: Impact of epigenetic driven and epigenetic independent reactivation of endogenous Klotho expression SERB Principal Investigator EMEQ 50.33
2
To study the role of hyperglycemia on the progression of acute kidney injury
SERB Principal Investigator Early Carrier Research Award 47.18
3 Understanding hyperglycemia induced alterations in non-coding RNA expression pattern and post translational histone protein modifications contributing to drug resistance and progression of pancreatic cancer DST-SERB Co-Principal Investigator EMR 40.32
4
Peptide decorated pH sensitive nanoconjugate hybrid micelles for codelivery of temozolamide and an autophagy inducer, rapamycin for treatment of glioblastoma multiforme
DBT Co-Principal Investigator Nanobiotechnology 41.94
5
Alternate day fasting resembles recurrent insulin-induced hypoglycemia model in rat
SERB Mentor NPDF 19.20
6 Role of histone ubiquitination & angiotensin converting enzyme 2 in the development of renal fibrosis under type I diabetic condition CSIR, Govt of India Principal Investigator EMR
14.86
7 Effect of esculetin on the development of type II diabetic nephropathy BITS Principal Investigator Research Initiation Grant  2.00
8 Effect of esculetin on angiotensin II in rat thoracic aorta under hyperglycaemic and hyperinsulinaemic conditions UGC, Govt of India Principal Investigator Major Research Proposal 13.43
9 Understanding the epigenetic regulation in modulating inflammatory response mediated by NF-kB through AT1 or AT2 receptor in type II diabetic nephropathy DST-SERB Principal Investigator Fast Track for Young Scientist 22.21
10 Esculetin a therapeutic intervention targeted at cardio-renal syndrome in type 2 diabetes DST-SERB Principal Investigator Empowerment and Equity Opportunities for Excellence in Science 39.66